0000898432-01-500360.txt : 20011018 0000898432-01-500360.hdr.sgml : 20011018 ACCESSION NUMBER: 0000898432-01-500360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20010930 FILED AS OF DATE: 20011010 COMPANY DATA: COMPANY CONFORMED NAME: BONMATI REYNALD G CENTRAL INDEX KEY: 0001006017 STANDARD INDUSTRIAL CLASSIFICATION: [] DIRECTOR FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: PREMIUM POINT CITY: NEW ROCHELLE STATE: NY ZIP: 10801 MAIL ADDRESS: STREET 1: PREMIUM POINT CITY: NEW ROCHELLE STATE: NY ZIP: 10801 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NORLAND MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000946428 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061387931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26206 FILM NUMBER: 1756283 BUSINESS ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 BUSINESS PHONE: 9146942285 MAIL ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 FORMER COMPANY: FORMER CONFORMED NAME: OSTECH INC DATE OF NAME CHANGE: 19950608 4 1 norland_form4.txt
------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION ------------------------- FORM 4 Washington, D.C. 20549 OMB APPROVAL ------------------- ------------------------- / / Check this box if no longer STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB Number: 3235-0287 subject to Section 16. Form Expires:December 31, 2001 4 or Form 5 obligations may Filed pursuant to Section 16(a) of the Securities Exchange Act of Estimated average burden continue. 1934, Section 17(a) of the Public Utility Holding Company Act of hours per response....0.5 SEE Instruction 1(b) 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Response) ------------------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person(s) to Issuer Bonmati Reynald G. Norland Medical Systems, Inc. (NRLD) (Check all applicable) ----------------------------------------------------------------------------------------------------- (Last) (First) (Middle) 3. IRS or Social Security 4. Statement for Month/Year X Director X 10% Owner Number of Reporting September, 2001 --- --- Person (Voluntary) X Officer --- Other ---(give title (specify Premium Point below) below) President & Chairman --------------------------------------------- ------------------------------------------------------- (Street) 5. If Amendment, Date of 7. Individual or Joint/Group Original (Month/Year) Filing (Check Applicable Line) New Rochelle NY 10801-5328 X Form filed by One --- Reporting Person --- Form filed by More than One Reporting Person ------------------------------------------------------------------------------------------------------------------------------------ (City) (State) (Zip) Table 1 - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Security 2. Trans- 3. Transaction 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of (Instr. 3) action Date Code or Disposed of (D) Securities Form: Indirect (Instr. 8) (Instr. 3, 4 and 5) Beneficially Direct Beneficial Owned at End (D) or Ownership of Month Indirect (Instr. 3 (I) (Month/Day/ --------------------------------------------- and 4) (Instr. 4) (Instr. 4) Year) Code V Amount (A) or (D) Price ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $.0005 9/21/01 J 87,842 D $.08 0 I See note (1) per share ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $.0005 per share 11,831,916 I See note (2) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $.0005 per share 9/21/01 J 17,568 A $0.08 1,081,878 I See note (3) ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $.0005 per share 9/21/01 J 70,274 A $0.08 D ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, par value $.0005 per share 9/21/01 S 200,000 D $0.08 4,000,230 D ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1474 (3-99) *If the form is filed by more than one reporting person, see Instruction 4(b)(v). Page 1 of 3 (Print or Type Response)
FORM 4 (continued) TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (E.G., puts, calls, warrants, options, convertible securities) ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Derivative 2. Conversion or 3. Transaction 4. Transaction 5. Number of Derivative 6. Date Exercisable Security (Instr. 3) Exercise Price Date Code Securities Acquired (A) and Expiration Date of Derivative Instr. 8) or Disposed of (D) Security (Month/Day/ (Instr. 3, 4 and 5) (Month/ Day/Year) Year) ---------------------------------------------------------------------- Code V (A) (D) Date Exercisable ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: /s/Marian E. Gustafson October 10, 2001 ------------------------------- ------------------- **Signature of Reporting Person Date BY: MARIAN E. GUSTAFSON FOR: REYNALD G. BONMATI ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. ** Signature of Reporting Person SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, SEE Instruction 6 for procedure. SEE Instruction 6 for procedure. Page 2 of 3
FORM 4 (continued) TABLE II(a) - Derivative Securities Acquired, Disposed of, or Beneficially Owned (E.G., puts, calls, warrants, options, convertible securities) ------------------------------------------------------------------------------------------------------------------------------------ 7. Title and Amount of 8. Price of Derivative Security 9. Number of derivative 10. Ownership Form of 11. Nature of Underlying Securities (Instr. 5) Securities Beneficially Derivative Security: Indirect (Instr. 3 and 4) Owned at End of Month Direct (D) or Beneficial (Instr. 4) Indirect (I) Ownership (Instr. 4) (Instr. 4) Amount or Number Title of Shares ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: /s/Marian E. Gustafson October 10, 2001 ------------------------------- ------------------- **Signature of Reporting Person Date BY: MARIAN E. GUSTAFSON FOR: REYNALD G. BONMATI ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. ** Signature of Reporting Person SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, SEE Instruction 6 for procedure. SEE Instruction 6 for procedure. Page 2a of 3
NOTES TO FORM 4 FILED BY REYNALD G. BONMATI: (1) On September 21, 2001, Novatech Resource Corporation distributed all of its 87,842 outstanding shares pro rata to its stockholders. Mr. Bonmati acquired 70,274 shares. Mr. Bonmati's wife acquired 17,568 shares as trustee of two trusts benefiting their children (See note (3)). (2) The amount of securities beneficially owned at the end of the month by the reporting person represents the aggregate number of shares indirectly owned by the reporting person. This amount represents 11,831,916 shares of the Issuer's common stock held by Bones, L.L.C., of which the reporting person is a managing member. The aggregate number of shares is reported under the SEC rules and staff interpretations, although the number includes shares in which the reporting person does not have a pecuniary interest. (3) The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein. In filing this Form 4 and reporting the information contained herein, the undersigned is not admitting to or conceding beneficial ownership of any securities or rights described herein pursuant to Sections 13 or 16 of the Securities Exchange Act of 1934, as amended, or any rule or regulation promulgated thereunder. The ownership figure represents shares owned by the reporting person's wife, as trustee of two trusts benefiting their children, the Sandrine Bonmati Trust and the Chrystele Bonmati Trust with respect to which the reporting person disclaims beneficial ownership. The Sandrine Bonmati Trust held a total of 531,600 shares of the issuer's common stock on September 21, 2001. The Chrystele Bonmati Trust held 550,278 shares on September 21, 2001.